Although the molecular mechanism by which the oxLDL-CD36 axis promotes CEBPβ expression remains to be defined, our findings underscore the regulatory role of the oxLDL-CD36-CEBPβ cascade to Nogo-B expression in NAFLD-associated hepatocarcinogenesis. The gene discussed is RTN4; the disease is metabolic dysfunction-associated steatotic liver disease.